This week's biotech landscape witnessed regulatory approvals across the U.S., Taiwan, and Europe, alongside FDA rejections, collaborations, acquisitions, and positive data readouts spanning multiple therapeutic areas, including Colorectal Cancer, Obesity and Fatty Liver Disease. Let's unpack the specifics. FDA and EU Approvals & Rejections Phillips Secures FDA Clearance for AI-Powered Verida Spectral CT Royal Philips (PHG) received FDA 510(k) clearance for its new Spectral CT Verida system, an AI-powered, d ...